- Home
- FIBK vs XENE Comparison
FIBK vs XENE Comparison
Compare FIBK & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIBK
- XENE
- Stock Information
- Founded
- FIBK 1879
- XENE 1996
- Country
- FIBK United States
- XENE Canada
- Employees
- FIBK N/A
- XENE N/A
- Industry
- FIBK Major Banks
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- FIBK Finance
- XENE Health Care
- Exchange
- FIBK Nasdaq
- XENE Nasdaq
- Market Cap
- FIBK 3.4B
- XENE 3.3B
- IPO Year
- FIBK 2010
- XENE 2014
- Fundamental
- Price
- FIBK $28.59
- XENE $34.26
- Analyst Decision
- FIBK Hold
- XENE Strong Buy
- Analyst Count
- FIBK 7
- XENE 7
- Target Price
- FIBK $36.14
- XENE $57.00
- AVG Volume (30 Days)
- FIBK 718.3K
- XENE 454.3K
- Earning Date
- FIBK 04-23-2025
- XENE 05-08-2025
- Dividend Yield
- FIBK 6.59%
- XENE N/A
- EPS Growth
- FIBK N/A
- XENE N/A
- EPS
- FIBK 2.19
- XENE N/A
- Revenue
- FIBK $931,900,000.00
- XENE N/A
- Revenue This Year
- FIBK $14.82
- XENE N/A
- Revenue Next Year
- FIBK $5.98
- XENE $826.46
- P/E Ratio
- FIBK $13.03
- XENE N/A
- Revenue Growth
- FIBK N/A
- XENE N/A
- 52 Week Low
- FIBK $24.16
- XENE $33.27
- 52 Week High
- FIBK $36.77
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- FIBK 39.50
- XENE 38.03
- Support Level
- FIBK $28.09
- XENE $33.62
- Resistance Level
- FIBK $29.79
- XENE $36.25
- Average True Range (ATR)
- FIBK 0.68
- XENE 1.22
- MACD
- FIBK 0.15
- XENE 0.02
- Stochastic Oscillator
- FIBK 48.72
- XENE 22.28
About FIBK First Interstate BancSystem Inc. (DE)
First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism, and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.